Skip to content
Loading...

Key Dates

  • 11 Aug - 04 Nov, 2025 Abstract submission period
  • 11 Aug - 18 Nov, 2025 Early registration fees
  • 15 Dec, 2025 Abstract notification
  • 19 Nov, 2025 - 25 Feb, 2026 Standard registration fees
  • 26 - 28 Feb, 2026 EASL SLD Summit 2026

The EASL SLD Summit 2026 aims at updating you on the most recent advances in Steatotic Liver Disease (SLD) including MASLD, MetALD and ALD research, both pre-clinically and clinically and looking into the potential interaction between the 2 most important drivers of SLD. The Summit is a unique opportunity to exchange with both young fellows and established experts in the field in a highly interactive format with a lot of room for discussion.

The Summit will explore whether public policy can reshape the pro-SLD environment, from urban planning to health regulation. A focal topic will this year on ultra processed food and SLD, challenging participants to reconsider the metabolic impact of modern diets.

You will gain insights of optimal patient care in an integrated perspective encompassing the whole spectrum of SLD from the stratification for severity, diagnosis of the subtypes of SLD and management of comorbidities and complications such as HCC in an holistic multidisciplinary approach including an often-overlooked question regarding the strategies to ensure continuity and personalization across life stages.

You will learn about the most recent techniques employed in research, clinical trials and clinical practice, with an understanding of their potential as well as limitations.

Finally, in an evolving landscape of therapies for MASH and MetALD, you will delve into the current and future therapeutic tracks focusing on metabolically directed therapies and liver-directed therapies and discuss whether these therapies should focus on fibrosis improvement or clinical outcomes.

We will conclude the conference by looking towards future horizons, opening a multidisciplinary discussion that builds on fixed points to improve our approach to SLD patient care.

Scope & Topics

  • Public health challenges
  • Patients care: screening, referral, management of comorbidities
  • Transition from pediatric to adult care in patients with SLD
  • Diagnosis and NITs in MASLD and MetALD
  • Understand the integration of Big Data and AI (Deep Learning, Transformers) in SLD diagnostics and pathology.
  • Explore single-cell and spatial omics technologies for targeted therapies.
  • Examine genetic and environmental factors, including alcohol, in SLD progression.
  • Discuss organoid bioengineering and multiorgan interactions in SLD.
  • Utilize metabolomics for multiorgan disease modeling (adipose tissue, liver, brain, gut).
  • Pharmacological approaches

Top reasons to attend:

To explore the latest scientific breakthroughs and clinical advances in SLD—spanning AI, omics, organoids, and public health—through a forward-looking and interactive programme.

To engage directly with leading experts and emerging voices in a dynamic, multidisciplinary format.

To present your work, exchange ideas, and expand your professional network in an interactive and inclusive environment.

To contribute to important discussions on therapeutic goals, care continuity, and the evolving role of SLD specialists.

Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Key Dates

  • 11 Aug - 04 Nov, 2025 Abstract submission period
  • 11 Aug - 18 Nov, 2025 Early registration fees
  • 15 Dec, 2025 Abstract notification
  • 19 Nov, 2025 - 25 Feb, 2026 Standard registration fees
  • 26 - 28 Feb, 2026 EASL SLD Summit 2026
Back To Top